National Opioid Litigation
The largest public health litigation in U.S. history. Cities, counties, states, and tribes are suing opioid manufacturers, distributors, and pharmacy chains for fueling the opioid epidemic that has claimed over 800,000 American lives since 1999.
Key Takeaways
- $50+ billion in total settlements to states and localities
- The largest public health litigation in U.S. history
- Over 800,000 Americans have died from opioid overdoses since 1999
- Purdue/Sackler settlement of $7 billion confirmed November 2025
- Settlements paid over 18-year period to fund treatment and prevention
Key Facts (June 2026)
| Pending Actions | 2,930 cases in federal MDL |
| Total Settlements | $50+ billion to states and localities |
| Distributor Settlement | $21 billion (McKesson, Cardinal, AmerisourceBergen) |
| Purdue/Sackler Settlement | $7 billion (confirmed November 2025) |
| Pharmacy Settlements | $13+ billion (CVS, Walgreens, Walmart) |
| Primary Plaintiffs | Cities, counties, states, tribes (NOT individuals) |
| MDL Consolidated | December 2017 |
| Presiding Judge | Hon. Dan Aaron Polster (N.D. Ohio) |
| Fund Usage Requirement | 85%+ must fund opioid abatement |
| Status | Actively Recruiting (new cases accepted) |
Case Tracking - 2025-2026
With major settlements in place, case count has stabilized with a slight -2% decline as claims are resolved. Most governmental plaintiffs have joined settlement agreements.
Source: JPML MDL Statistics Reports, January 2025-June 2026
1 What Is This Litigation?
The National Prescription Opiate Litigation (MDL-2804) is a massive consolidation of lawsuits filed by cities, counties, states, and Native American tribes against the companies they allege caused and profited from the opioid epidemic.
This is NOT Individual Injury Litigation
Unlike most MDLs, this litigation is primarily governmental—plaintiffs are local and state governments seeking to recover public costs incurred responding to the opioid crisis: emergency services, healthcare, law enforcement, social services, and more. Individual overdose victims and their families generally are not part of this MDL.
Defendants include drug manufacturers (Purdue Pharma, Johnson & Johnson, Teva), the "Big Three" distributors (McKesson, Cardinal Health, AmerisourceBergen), and major pharmacy chains (CVS, Walgreens, Walmart). Collectively, over $50 billion in settlements have been reached.
2 The Opioid Crisis: Three Waves
Prescription Opioid Deaths
Increased prescribing of opioids began in the 1990s, driven by campaigns minimizing addiction risks. Opioid prescribing increased fourfold from 1999-2010, paralleled by a fourfold increase in overdose deaths.
Heroin Deaths
As prescription opioids became harder to obtain, many users transitioned to heroin. Heroin overdose deaths increased rapidly starting in 2010, though they have declined in recent years (down 33% from 2022-2023).
Synthetic Opioid Deaths (Fentanyl)
Illegally manufactured fentanyl (50-100x more potent than morphine) has saturated the drug supply. Fentanyl is now the leading cause of opioid deaths, often found in counterfeit pills or mixed with other drugs.
Source: CDC, NIDA. OUD = Opioid Use Disorder
3 The Defendants
M Manufacturers
Developed OxyContin in 1995. Alleged aggressive marketing downplaying addiction risks. Filed bankruptcy 2019, settlement confirmed November 2025.
Manufactured opioids through Janssen; supplied ingredients through Noramco. Ceased opioid sales 2020.
Major generic opioid manufacturer. Settlement includes $1.2B in generic Narcan (naloxone).
Opioid manufacturer; agreed to settlement provisions over 7 years.
D Distributors ("Big Three")
Paid over 18 years. Required to create clearinghouse to detect and report suspicious opioid orders.
Alleged to have failed "suspicious order monitoring" obligations—shipping massive quantities to pharmacies despite clear red flags.
P Pharmacy Chains
Alleged to have filled prescriptions from "pill mills" and failed to train pharmacists to identify red flags.
4 The $50+ Billion in Settlements
| Defendant(s) | Amount | Timeline |
|---|---|---|
| Distributors (McKesson, Cardinal, Cencora) | $21B | 18 years |
| Purdue Pharma / Sackler Family | $7B | Confirmed Nov 2025 |
| Walgreens | $5.52B | 15 years |
| Johnson & Johnson | $5B | 9 years |
| CVS Health | $4.90B | 10 years |
| Teva (cash + Narcan) | $4.5B+ | 13 years |
| Walmart | $2.74B | 6 years |
| Allergan | $2.02B | 7 years |
| TOTAL | $50B+ |
5 How Settlement Funds Must Be Used
Treatment & Recovery
- • Medication-assisted treatment (MAT)
- • Substance use disorder facilities
- • Recovery support services
- • Treatment for pregnant women with OUD
Harm Reduction
- • Naloxone (Narcan) distribution
- • Syringe services programs
- • Fentanyl test strip distribution
- • Overdose prevention education
Prevention Programs
- • Youth prevention education
- • Prescriber training
- • Public awareness campaigns
- • Early intervention services
Criminal Justice
- • Drug courts
- • Diversion programs
- • Jail-based treatment
- • Reentry support services
6 Who Are the Plaintiffs?
Cities, Counties & Municipalities
The vast majority of plaintiffs are local governments seeking to recover costs from emergency services, healthcare, law enforcement, foster care, and social services strained by the opioid crisis.
States (Often Separate from MDL)
Many states filed independent litigation through their Attorneys General, pursuing separate settlements. State claims may be coordinated with but distinct from the federal MDL.
Native American Tribes
Federally recognized tribes have filed claims alleging disproportionate impact on tribal communities. Tribal claims are not settled by the national settlement agreements.
Hospital Systems & Insurers
Healthcare providers and insurers have filed claims seeking to recover treatment costs and payments made for opioid prescriptions.
7 Frequently Asked Questions
Can individuals sue for opioid-related injuries?
Where is the settlement money going?
Why is the MDL still "actively recruiting"?
What happened to Purdue Pharma and the Sacklers?
Are opioids still being prescribed?
Is the opioid crisis getting better?
Sources & References
6 official sources citedJudicial Panel on Multidistrict Litigation (JPML) — Official MDL statistics
CDC Overdose Prevention — Opioid crisis statistics and three waves
NIDA — Opioid classification and research
National Opioid Settlement — Settlement details and allocations
Johns Hopkins Opioid Principles — Settlement fund tracking
CDC Clinical Practice Guideline for Prescribing Opioids, 2022. Data current as of June 2026.
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.
Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.